小类心籽（新命名）和波缘靓籽（比较种）的结构与个体发育研究

本文报道了在中国山西太原晚石炭世煤核中发现的两种不同类型种子：小类心籽（新命名）Nucellangium minor nom. nov. 和波缘靓籽（比较种）Callospermarion cf. undulatum, 它们分别属于心籽目（Cardiocarpales)的类心籽属（Nucellangium）和靓籽属（Callospermarion）。 小类心籽为科达类植物种子，两侧对称，厚心形，主切面长约4-6mm，宽3-4mm，次切面厚约2.5-3.0mm。成熟种子的珠被由肉质层、硬质层组成，内表层由7-10层大型薄壁细胞组成，只存在于未成熟种子。肉质层外有一角质层和表皮层，肉质层分为两个亚层;外层细胞扁长，有深色内含物，内层无内含物，由薄壁细胞组成，越往内越小，硬质层外缘光滑无刺突，分为两个纤维细胞亚层，外层细胞壁厚直径小，内层细胞直径增大细胞壁变薄，沿纵切方向伸长。珠心除基部外游离于珠被。双维管系统由分布在肉质层的珠被维管束和呈套状分布的珠心维管束组成，组成珠心维管束的管胞为梯纹状加厚。文章对类心籽属的特征作了修正，并以小类心籽的形态、大小和珠被结构等特征为依据，就它的个体发育进行了探讨，证明晚出同名的小心籽（Cardiocarpus minor Wang 1987）为当前小类心籽个体发育的早期阶段。 波缘靓籽（比较种）（Callospermarion cf. undulatum)为靓羊齿植物（Callistophytales）种子，两侧对称，三层珠被，肉质层占据珠被的大部分，有分泌腔分布，肉质层外缘呈波缘状。珠心除了在基部外，游离于珠被。维管束分布在翼部肉质层内侧。首次在太原的靓籽属种子中发现了具有重要意义的特征性结构——分泌腔。还就山西太原发现的波缘靓籽所代表的个体发育阶段进行了讨论。 文中还分别讨论了这两类种子各自的亲缘关系。

1.5 V battery driven reduced graphene oxide-silver nanostructure coated carbon foam (rGO-Ag-CF) for the purification of drinking water

A porous carbon foam (CF) electrode modified with a reduced graphene oxide-Ag (rGO-Ag) nanocomposite has been fabricated to purify water. It can perform as an antibacterial device by killing pathogenic microbes with the aid of a 1.5 V battery, with very little power consumption. The device is recycled ten times with good performance for long term usage. It is shown that the device may be implemented as a fast water purifier to deactivate the pathogens in drinking water.

Convocação de ministros de Estado pelo Poder Legislativo (CF, art. 10)

Examina quais as medidas cabíveis no caso de não comparecimento de Ministro de Estado convocado por Comissão da Câmara dos Deputados.

［（μ－CF���3CO＿2）＿2Ln（μ－CF���3HCO＿2）Al（i－Bu）＿2·2THFl＿2（Ln＝Nd，Y）配合物的NMR和X－射线衍射研究

对［μ－ＣＦ＿３ＣＯ＿２）＿２Ｌｎ（μ－ＣＦ＿３ＨＣＯ＿２）Ａｌ（ｉ－Ｂｕ）＿２·ＴＨＦｌ＿２（Ｌｎ＝Ｎｄ，Ｙ）配合物单晶结构的Ｘ－射线分析指出，配合物具有中心对称性，配位中心由两个稀土和两个Ａｌ离子组成，稀土由两个ＴＨＦ和６个ＴＦＡ分子配位形成畸变的三盖三棱柱结构，Ａｌ由两个ＴＦＡＧ和两个ｉ－Ｂｕ配位形成四面体结构。桥连Ａｌ与两个稀土的ＴＦＡ分子的羧基发生歧化加氢，其碳原子由ＳＰ￣２型转变为ＳＰ￣３型．ＮＭＲ研究表明，在ＴＨＦ溶液中，该配合物保持了它在单晶中的配位结构，所不同的是两个ｉ－Ｂｕ在溶液中有两种异构形成，二者间为慢交换过程。

Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF)

Yeasts and filamentous fungi are beginning to emerge as significant microbial pathogens in patients with cystic fibrosis (CF), particularly in relation to allergic-type responses, as seen in patients with allergic bronchopulmonary aspergillosis (ABPA), Aspergillus bronchitis and in invasive fungal disease in lung transplant patients. Four fungal media were compared in this study, including Sabouraud Dextrose Agar (SDA) and Medium B, with and without the addition of selective antibiotics, where antibiotic-supplemented media were designated with (+). These media were compared for their ability to suppress contaminating, mainly Gram-ve pathogens, in CF sputa (Pseudomonas aeruginosa, Burkholderia cepacia complex [BCC] organisms) and to enhance the growth of fungi present in CF sputum. Medium B consisted of glucose (16.7 g/l), agar (20 g/l), yeast extract (30 g/l) and peptone (6.8 g/l) at pH 6.3 and both SDA(+) and Medium B+ were supplemented with cotrimethoxazole, 128 mg/l; chloramphenicol, 50 mg/l; ceftazidime, 32 mg/l; colistin, 24 mg/l). Employment of SDA(+) or Medium B+ allowed an increase in specificity in the detection of yeasts and moulds, by 42.8% and 39.3%, respectively, over SDA when used solely. SDA(+) had a greater ability than Medium B+ to suppress bacterial growth from predominantly Gram-ve co-colonisers. This is a significant benefit when attempting to detect and isolate fungi from the sputum of CF patients, as it largely suppressed any bacterial growth, with the exception of the BCC organisms, thus allowing for an increased opportunity to detect target fungal organisms in sputum and represented a significant improvement over the commercial medium (SDA), which is currently used. Overall, both novel selective media were superior in their ability to suppress bacteria in comparison with the commercially available SDA medium, which is routinely employed in most clinical microbiology diagnostic laboratories presently. Alternatively, Medium B+ had a great ability to grow fungi than SDA(+) and when employed together, the specificity of combined use was 82%, with a sensitivity for yeasts, filamentous fungi, and combined overall fungi of 96.0%, 92.3% and 96.0%, respectively. Overall, when employing one fungal selective medium for the routine detection of yeasts and filamentous fungi in the sputum of CF patients, we would recommend employment of Medium B+. However, we would recommend the combined employment of SDA(+) and Medium B+, in order to synergistically isolate and detect the greatest number of fungi present in CF sputa. (C) 2008 European Cystic Fibrosis Society. Published by Elsevier B.V All rights reserved.

Copying letters to patients with cystic fibrosis (CF): Letter content and patient perceptions of benefit

Background: Copying letters involves generating an extra copy of all correspondence between healthcare professionals about the patient, to the patient.

Development of a novel PCR assay for the identification of the black yeast, Exophiala (Wangiella) dermatitidis from adult patients with cystic fibrosis (CF)

Cystic fibrosis (CF) patients may suffer increased morbidity and mortality through colonisation, allergy and invasive infection from fungi. The black yeast, Exophiala dermatitidis (synonym Wangiella dermatitidis) has been found with increasing frequency in sputum specimens of CF patients, with reported isolation rates ranging from 1.1 to 15.7%. At present, no diagnostic PCR exists to aid with the clinical laboratory detection and identification of this organism. A novel species-specific PCR-based assay was developed for the detection of E. dermatitidis, based on employment of rDNA operons and interspacer (ITS) regions between these rDNA operons. Two novel primers, (designated ExdF & ExdR) were designed in silico with the aid of computer-aided alignment software and with the alignment of multiple species of Exophiala, as well as with other commonly described yeasts and filamentous fungi within CF sputum, including Candida. Aspergillus and Scedosporium. An amplicon of approximately 455 by was generated, spanning the partial ITS I region - the complete 5.8S rDNA region - partial ITS2 region, employing ExdF (forward primer [16-mer], 5'-CCG CCT ATT CAG GTC C-3' and ExdR (reverse primer [16-mer], 5'-TCT CTC CCA CTC CCG C-3', was employed and optimised on extracted genomic DNA from a well characterised culture of E. dermatitidis, as well as with high quality genomic DNA template from a further 16 unrelated fungi, including Candida albicans, C. dubliniensis, C. parapsilosis, C. glabrata, Scedosporium apiospermum, Penicillium sp., Aspergillus fumigatus, Aspergillus versicolor, Pichia guilliermondii, Rhodotorula sp., Trichosporon sp., Aureobasidium pullulans, Fusarium sp., Mucor hiemalis, Bionectria ochroleuca, Gibberella pulicaris. Results demonstrated that only DNA from E. dermatitidis gave an amplification product of the expected sire, whilst none of the other fungi were amplifiable. Subsequent employment of this primer pair detected this yeast from mycological cultures from 2/50 (4%) adult CF patients. These two patients were the only patients who were previously shown to have a cultural history of E. dermatitidis from their sputum. E. dermatitidis is a slow-growing fungus, which usually takes up to two weeks to culture in the microbiology laboratory and therefore is slow to detect conventionally, with the risk of bacterial overgrowth from common co-habiting pan- and multiresistant bacterial pathogens from sputum. namely Pseudomonas aeruginosa and Burkholderia cepacia complex organisms, hence this species-specific PCR assay may help detect this organism from CF sputum more specifically and rapidly. Overall, employment of this novel assay nay help in the understanding of the occurrence. aetiology and epidemiology of E. dermatitidis, as an emerging fungal agent in patients with CF. (C) 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.